Zepbound KwikPen
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0002-3544 -
Package NDC
0002-3544-11 -
Application number
NDA217806 -
SPL ID
a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fc -
SPL set ID
487cd7e7-434c-4925-99fa-aa80b1cc776b -
UNII
OYN3CCI6QE -
RxCUI
2601743 -
RxCUI
2601755 -
RxCUI
2601761 -
RxCUI
2601767 -
RxCUI
2601773 -
RxCUI
2601784 -
RxCUI
2644396 -
RxCUI
2644401 -
RxCUI
2644405 -
RxCUI
2644409 -
RxCUI
2644413 -
RxCUI
2644417 -
RxCUI
2669706 -
RxCUI
2669709 -
RxCUI
2669712 -
RxCUI
2669715 -
RxCUI
2669718 -
RxCUI
2669721 -
RxCUI
2679317 -
RxCUI
2679319 -
RxCUI
2679321 -
RxCUI
2679323 -
RxCUI
2679325 -
RxCUI
2679327 -
RxCUI
2732437 -
RxCUI
2732440 -
RxCUI
2732442 -
RxCUI
2732444 -
RxCUI
2732446 -
RxCUI
2732448 -
RxCUI
2732449 -
RxCUI
2732450 -
RxCUI
2732452 -
RxCUI
2732454 -
RxCUI
2732456 -
RxCUI
2732458 -
RxCUI
2734623 -
RxCUI
2734626 -
RxCUI
2734628 -
RxCUI
2734630 -
RxCUI
2734632 -
RxCUI
2734634 -
RxCUI
2734636 -
RxCUI
2734638 -
RxCUI
2734640 -
RxCUI
2734642 -
RxCUI
2734644 -
RxCUI
2734646
What the source publishes
- Labeler
- Eli Lilly and Company
- Active ingredients
- tirzepatide
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Zepbound KwikPen",
"splId": "a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fc",
"labels": [
{
"setId": "487cd7e7-434c-4925-99fa-aa80b1cc776b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=487cd7e7-434c-4925-99fa-aa80b1cc776b"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Eli Lilly and Company",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE in 1 CARTON (0002-3544-11) / 2.4 mL in 1 SYRINGE (0002-3544-01)",
"package_ndc": "0002-3544-11",
"identifierStatus": "well-formed",
"marketing_start_date": "20260120"
}
],
"productId": "0002-3544_a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fc",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0002-3544",
"deaSchedule": null,
"genericName": "tirzepatide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TIRZEPATIDE",
"strength": "12.5 mg/mL"
}
],
"applicationNumber": "NDA217806",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260120",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194015",
"N0000000152",
"N0000178480",
"N0000020058"
],
"upc": [
"0300022002045",
"0300026210118",
"0300021423049",
"0300020152049",
"0300026052114",
"0300021214043",
"0300026103113",
"0300026612110",
"0300021340049",
"0300026304114",
"0300026523119",
"0300020243044"
],
"unii": [
"OYN3CCI6QE"
],
"rxcui": [
"2601743",
"2601755",
"2601761",
"2601767",
"2601773",
"2601784",
"2644396",
"2644401",
"2644405",
"2644409",
"2644413",
"2644417",
"2669706",
"2669709",
"2669712",
"2669715",
"2669718",
"2669721",
"2679317",
"2679319",
"2679321",
"2679323",
"2679325",
"2679327",
"2732437",
"2732440",
"2732442",
"2732444",
"2732446",
"2732448",
"2732449",
"2732450",
"2732452",
"2732454",
"2732456",
"2732458",
"2734623",
"2734626",
"2734628",
"2734630",
"2734632",
"2734634",
"2734636",
"2734638",
"2734640",
"2734642",
"2734644",
"2734646"
],
"spl_set_id": [
"487cd7e7-434c-4925-99fa-aa80b1cc776b"
],
"pharm_class_epc": [
"Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]",
"GLP-1 Receptor Agonist [EPC]"
],
"pharm_class_moa": [
"G-Protein-linked Receptor Interactions [MoA]",
"Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
],
"manufacturer_name": [
"Eli Lilly and Company"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0002-3544_a5dba1a3-f7f7-4b8d-b9f1-a09dcdc1b2fc"